It’s the age of Ozempic — and America’s favorite weight-loss shots are impacting more than just metabolism.
Across the country, nearly one in five US adults say they’ve tried a GLP-1 drug to slim down or treat chronic conditions like diabetes or heart disease, producing countless success stories.
But behind closed doors, doctors say the drugs are also feeding a dangerous obsession with food and body image that has taken over some patients’ lives.
Read more at https://nypost.com/2026/01/30/health/people-are-developing-new-eating-disorders-on-glp-1-drugs/
The New York Post is your source for breaking news, news about New York, sports, business, entertainment, opinion, real estate, culture, fashion, and more.
Check out our three new podcasts:
NYNext (week): https://www.youtube.com/@nynext1
Pod Force One with MIranda Devine (weekly): https://www.youtube.com/@PodForce1
NY POSTcast (daily): https://www.youtube.com/@NYPOSTcast
Get The Post’s latest headlines everyday with our Morning Report newsletter:
https://tinyurl.com/NYPOSTSIGNUP
Catch the latest news at http://www.nypost.com.
Follow The New York Post on:
Twitter – https://twitter.com/nypost
Facebook – https://www.facebook.com/NYPost
